A bone marrow-homing heptapeptide [113] was tested, among other targeting moieties, for the delivery of SSO to bone marrow in order to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria [90]. The gene discussed is FECH; the disease is erythropoietic protoporphyria.